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ABSTRACT    
Objectives: This study aimed at assessing the clinical features and haematological 
parameters in sickler Sudanese patients attending El Obeid Hospitals in North 
Kordofan, Sudan.   
Materials and Methods: Eighty five patients with homozygous sickle cell (SS) disease, 
(both sexes) were included in this study. Their age ranged between 6 months to 42 
years. Forty persons were used as control.   
Clinical manifestations were recorded at examination. Freshly obtained blood samples 
from patients and control were used to estimate haematological parameters which 
included: haemoglobin concentration (Hb), packed cell volume (PCV), red blood cell 
count (RBC), white blood cell count (WBC), mean corpuscular haemoglobin (MCH), 
mean corpuscular volume (MCV), and erythrocyte sedimentation rate (E.S.R).   
                
Results: The clinical investigations revealed that all patients presented with painful 
crisis, 96.5% had chronic anemia, 84.7% had recurrent malaria and 81.2% had different 
infections (76% was chest infection). 32.9% of the sickle cell disease (SCD) patients 
had no blood transfusion, while the rest had blood transfused once to five times. 
Haematological measurement indicate that all SCD patients in this study were reported 
anaemic, and their Hb, PCV and RBC count were significantly lower (P<0.001) 
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compared with the control group, while WBC count and MCV were significantly higher 
(P<0.001, P<0.01). In this study the prevalence of SCD in Misseria tribe (24.7%) was 
highest compared to other tribes.   
Conclusion: This study affirmed the problem of sickle cell disease in Kordofan state, 
which should draw attention toward the need of further studies.   
   




INTRODUCTION    
There are two main large foci of the sickle gene among the Sudanese population, the 
Baggara "Negro-Arab" tribe in Western Sudan and Southern Nilotics of Equatoria 
Province, Southern Sudan (1,2) . A survey reported a sickling rate ranging from zero to 
18 percent among different tribes (3) . A survey done in Kordofan reported a prevalence 
of 18% in the Messieria Humur tribe (4), and up to 30.4% among Misserria tribe of 
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Darfur (5) . Other results showed that Messeria which was an Afro-asiatic tribe possesses 
a high prevalence of sickle cell trait in Sudan (6). Another study indicated that 84% of 
SCD patients were from Bagara tribe in Western Sudan, where HbS is a natural 
extension of the West African HbS belt (7).   
Variation in the complications of sickle cell disease (SCD) was found in Sudanese 
patients which included: gallstones (8) , dacylitis, liver enlargement and cardiac 
complications, haemolytic anaemia (9, 7) , painful crisis of the vaso-occlusive type 
followed by fever, pneumonia and osteomyelitis  (9) .   
Haematological parameters in SCD patients in Sudan were studied extensively in 
Khartoum. Iron deficiency (10)  , and haemolytic anaemia (11, 12)  were reported.   
Because of the different movements of the tribes and the intermarriages, the disease is 
now seen in different regions in Sudan, so variation in clinical and haematological 
parameters are expected. This study aimed at assessing the clinical and haematological 
variables in sickler Sudanese attending El Obeid hospitals in North Kordofan, Sudan.   
   
MATERIALS AND METHODS   
This case  control study was conducted on known sickler patients (HbSS) diagnosed by 
physicians depending on the clinical pictures and laboratory investigations (sickling test 
and electrophoresis). The study group were: eighty five sickle cell disease (SCD) 
patients attending El Obeid hospitals during May 2003  January 2004; forty subjects 
were used as control group. A questionnaire was designed to obtain information about 
age, sex, tribe, weight, height, education, occupation, SCD complications and family 
history. Venous blood samples were collected from each patient and transferred to 
polyethylene vials coated with an anticoagulant (EDTA). A manual haemocytometer 
and haematology analyzer were used for duplicate determinations of white blood cell 
count (WBC), red cell count (RBC) and platelets count according to standard methods. 
Sickling test, differential leucocyte count and RBC morphology examination were also 
done. Erythrocyte sedimentation rate (ESR) and packed cell volume (PCV) were 
determined. Mean corpuscular haemoglobin (MCH) and mean corpuscular volume 
(MCV) were calculated.   
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Analysis of variance (one way ANOVA) was applied for comparison between different 
groups. P value was considered significant at a value less than 0.05.    
   
RESULTS   
The clinical manifestations of sickle cell disease (SCD) patients are presented in   
Table 1. All SCD patients suffered from painful crises, while chromic anaemia, 
recurrent malaria and infections scored high prevalence in them .The common type of 
infection was chest infection (76.5%), and osteomyelitis (4.7%). Of the 85 SCD patients 
57 (67.1%) had blood transfusion one to five times, while the rest had no blood 
transfusion. 63 (74%) SCD patients had Hb concentration between 6.1  9.0 g/dL, while 
19 (22.4%) of the patients had Hb concentration less than 6 g/dL, which was 
significantly lower compared with the control group (Hb>10g/dL). 3 patients (3.5%) 
had haemoglobin concentration of 10g/dl.   
PCV and RBCs count were significantly lower in SCD patients compared with control 
subjects, whereas white blood count (WBC) and mean corpuscular volume (MCV) were 
significantly higher (Table 2). Differential leucocyte count (Table 3) showed significant 
differences between SCD patients and control group. RBC morphology was found 
normal in 24.6% of SCD patients, while 57 (67.1%) of them suffered from 
anisopikilocytosis (Table 4).    
Significant differences were found in weight and height between SCD patients and 
control group. The weight (kg) of the patients (n=85) was 27.3– 14.9 whereas that of 
the control (n=40) was 57.3– 18.5 (P<0.001).    
The height (cm) of the patients was 131.4– 29.3 whereas that of the control was 156.6–  
16.2 (P<0.001).   
The age and sex distribution is presented in Table 5. The ratio of males to females was 
1.18:1 for sickle cell patients. Most of the cases of SCD (68.3%) were in patients less 
than 15 years old.   
The ethnic groups showed highest prevalence of SCD in Messeria tribe (24.7%), 
followed by Hawazma tribe (20.0%), Barno, Falata and Dagese (16.5%), Bederia 
(14.1%), Gawammea (10.6%), Bani Halba (7.1%), Nuba (5.9%) and Hessanat and 
Maganeen (1.2%).   
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Table 1. Clinical findings and complications in the studied sickle cell disease patients   
Clinical findings and complications   (n=85)   %   
Painful crisis   85   100.0   
Chronic anaemia   85   100.0   
Recurrent malaria   72   84.7   
Infections   69   81.2   
Foot hand syndrome   56   65.9   
Jaundice   47   55.3   
Ocular problem   23   27.1   
Haematouria   12   14.1   
Leg ulcer   12   14.1   
Priapism   13   15.3   
Gallstones   5   5.9   
   
n= Number of Patients   
   
Table 2. Haematological parameters in patients and control group (Mean–SD)   
Variable   Patients (n = 85)   Control ( n = 40)   Significance   
Hb (g/dL)   7.12 – 1.3   12.82 – 1.33   S ***   
P.C.V (%)   21.7 – 4.2   38.9 – 4.4   S ***   
RBC count (1012/L)   2.51 – 0.78   4.74 – 0.46   S ***   
MCV (fl)   92.5–31.81   80.1–3.7   S **   
MCH (pg)   30.76 – 10.05   29.3–1.24   N.S   
E.S.R (mm/1 hr)   21.2–20.6   17.6–6.6   N.S   
WBC count (109/L)   12.57–4.56   5.88–1.49   S ***   
   
n= Number of subjects   
* = Statistically significant P < 0.05   
** = statistically significant P < 0.01    
*** = statistically significant P < 0.001    
N.S = statistically not significant  SD = standard 
deviation    
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Table 3.  Differential leucocyte count in the patients and control (Mean – SD)   
Variable   Patients (n = 85)   Control ( n = 40)   Significance   
Neutrophil    50.34–5.1   56.1–5.19   S ***   
Lymphocyte   43.85–4.95   38.9–5.31   S ***   
Monocyte    3.16–1.55   4.06–1.43   S ***   
Eosinophil   1.35–1.55   0.87–0.75   S ***   
n= Number of subjects   
* = Statistically significant P < 0.05   
** = statistically significant P < 0.01    
*** = statistically significant P < 0.001    
   
Table 4:  Red blood cells morphology in sickle cell patients and control groups n=  
Number of subjects   
Finding   Patients (n=85)  Control (n=40)   
   N  %  N  %  
Normocytic normochromic   21  24.6  40  100  
Anisopoikilocytosis   57  67.1  0  0  
Normocytic hypochromic   3  3.5  0  0  
Microcytic hypochromic   2  2.4  0  0  
   
Table 5. Age and sex distribution of the studied SCD patients   
Age group (year)   Male     Female     Total     
No   %   No   %   No   %   
<2   2   4.3   3   7.7   5   5.9   
2-8   22   47.8   14   35.9   36   42.4   
9-15   9   19.6   8   20.5   17   20.0   
16-22   4   8.7   4   10.3   8   9.4   
23-29   3   6.5   6   15.4   9   10.6   
> 29   6   13.0   4   10.3   10   11.8   
Total   46     39     85     
   
   
DISCUSSION   
In this study all patients were homozygous sickle cell anaemia patients (HbSS).   
The common clinical findings observed were chronic anaemia, and painful crisis.   
                
These two findings were common in SCD patients (12-16), but not common in Indian 
patients (17). Recurrent malaria was also reported in this study, which indicates that the 
occurrence of malaria (P. Falciparum) in homozygous sickle cell (SS disease) is almost 
certainly a major determinant of morbidity and mortality (18) ,in contrast to the (AS) trait 
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who have resistance to this parasite. Chest infection was reported high in this study. 
This agrees with Al Dabbous, 2002; Stuart, 1999 (19, 20) but not in line with other studies 
that reported various infectious diseases other than chest infection (7,12) . Due to 
excessive haemolysis of sickled RBCs and according to the WHO criteria 
(Hb<11.012.0 g/dL), all SCD patients in this study were anaemic, and their mean 
Haemoglobin  
(Hb) concentration was significantly (P<0.001) lower compared with the control group.  
This result agrees with Bayoumi, 1988; Awad, 1992; Nduka, 1993; Kar et al, 1986 (7,  
21, 22)   . Most of the patients in this study had blood transfusion once to five times. This 
may explain the presence of normocytic normocromic erythrocytes in SCD patients. 
Despite the highly significant difference in mean corpuscular volume (MCV) between 
the two groups; it falls within the reference range. This finding agrees with Beharman 
(1996) (23) , who also found that RBC morphology in SCD patients was normochromic 
normocytic, and their platelets were increased, while in this study the 
anisopoikilocytosis was reported high, and only 27 (31.8%) SCD patients had increased 
platelets. White blood cell count (WBC) was significantly higher in SCD patients. Our 
finding that packed cell volume (PCV) and red blood cell count (RBC) were 
significantly lower in SCD patients compared with control subjects is in line with 
ElHazmi et al, 1987; Nduka, 1993 and Kar et al, 1986  (17,22,24) . In general, erythrocyte 
sedimentation rates (E.S.R) in SCD patients is low probably because of abnormal shape 
of sickle cells that prevent relax formation. In this study E.S.R was higher in SCD 
patients compared with control. A significant difference was found in weight and height 
between SCD patients and control group. This result agrees with others who found that 
impaired growth is common, and there is early decrease in height and weight (25).    
The prevalence of SCD was found higher in Messeria which was an Afro-asiatic tribe 
followed by Hawazma. This result is in agreement with Atalla et al, 2003; Ibrahim, 
1970; and Vella, 1964, (4-6)  while another study found that the prevalence of SCD in 
Bagara tribe was higher compared with other tribes (7) . This difference can perhaps be 
accounted for by the small sample size in these studies which may not be representative 
of the tribes of the whole population.   
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